ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr | ₹5,393 Cr | ₹4,606 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2025 | ₹6,229 Cr |
Mar2024 | ₹5,653 Cr |
Mar2023 | ₹5,306 Cr |
Mar2022 | ₹5,393 Cr |
Mar2021 | ₹4,606 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹6,229 Cr | 10.19 | |
Mar2024 | ₹5,653 Cr | 6.54 | |
Mar2023 | ₹5,306 Cr | -1.62 | |
Mar2022 | ₹5,393 Cr | 17.10 | |
Mar2021 | ₹4,606 Cr | - |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹18,818.6 Cr | -1.6% | -2.5% | -20.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -1.6% |
-2.5% |
-20.2% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses